GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • American Association for Cancer Research (AACR)  (7)
  • 1
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2012
    In:  Cancer Research Vol. 72, No. 8_Supplement ( 2012-04-15), p. 58-58
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 72, No. 8_Supplement ( 2012-04-15), p. 58-58
    Abstract: Cancer is fundamentally a disease of aberrant tissue growth and determining accurate progression in malignancies is of significant importance for the understanding of the heterogeneous growth patterns, and irregular nature of malignant tumors. Here we used two different imaging modalities to detect tumor progression, and highlight the inherent challenges with accurate determination of growth characteristics. The main focus in this study was to examine the differences in compound deposition and uptake into orthotopically and subcutaneously implanted tumors. Several perfusion studies with Indocyanine green (ICG) were performed and compound kinetics and distribution within the tumors were determined by MSOT and FMT-XCT. Multi-Spectral Optoacoustic Tomography (MSOT) is a powerful novel imaging modality that decomposes the spectral responses of endogenous and exogenous chromophores in vivo, with high resolution and at depths ranging from several millimeters to centimeters. Therefore, it can simultaneously detect and separate the signal of endogenous chromophores such as (oxy)hemoglobin and extrinsically administered photo-absorbing agents such as ICG and nanoparticles. FMT-XCT is an imaging system that integrates X-ray computed tomography (XCT) and fluorescence molecular tomography (FMT), enabling quantitative, volumetric detection of fluorescent agents with co-registration of anatomical features. For the subcutaneous model, HT29 human colon adenocarcinoma cells (∼106) were injected subcutaneously in the hind limb of CD1 nude mice (Charles River Laboratories, Germany). For the syngeneic, orthotopic model, Balb/c mice (Charles River Laboratories, Germany) were injected with 4T1 mouse mammary tumor cells (∼0.5x106) into the mammary fat pad. With MSOT imaging after ICG injection (50µg) we were able to show that the vascular perfusion of subcutaneous tumors was limited to the outer edges of the tumor, caused by necrosis within these tumors. The orthotopically implanted tumors were much better perfused and compound delivery throughout the entire tumor was achieved. A major advantage of MSOT imaging compared to FMT-XCT is that contrast agents and oxygenated vs. deoxygenated hemoglobin can be visualized non-invasively at the tumor site simultaneously with high spatial resolution, in real time, and throughout the entire period of tumor growth. Using FMT-XCT we were able to assess further information about the three-dimensional distribution of ICG within the entire animal. These findings show that the heterogeneity of tumors can be visualized non-invasively using MSOT and FMT-XCT. MSOT has the added advantage that endogenous chromophores such as hemoglobin can be resolved simultaneously. These imaging strategies are of critical importance to monitor tumor progression in order to evaluate appropriate treatment regimens and/ or stratify tumors based on oxygenation status. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 58. doi:1538-7445.AM2012-58
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2012
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2012
    In:  Cancer Research Vol. 72, No. 8_Supplement ( 2012-04-15), p. 2445-2445
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 72, No. 8_Supplement ( 2012-04-15), p. 2445-2445
    Abstract: High grade glioblastomas are aggressive and highly invasive tumors that rarely are curable. To investigate novel treatments, accurate orthotopic tumor-models are crucial to evaluate efficacy. Because caliper measurements are not possible in this setting, accurate imaging strategies are needed for temporal tumor-tracking. Here we present a novel imaging strategy that leverages the recent development of fluorescent proteins absorbing light in the near infrared region, enabling their application in visualizing biological processes in deep seated tissues such as orthotopic glioblastomas. While purely optical in vivo imaging methods can only provide insufficient resolution limited by scattering, multispectral optoacoustic tomography (MSOT) is a very well suited hybrid imaging modality that can provide noninvasive imaging of optical absorbers at ultrasound resolution. MSOT is based on the photoacoustic effect; the generation of ultrasound waves as a result of the transient heating and expansion that takes place after the absorption of nanosecond laser pulses. We have developed a preclinical MSOT whole animal scanner that makes use of a tomographic ultrasound transducer array to achieve fast image rates of 10Hz, while high penetration depths can be achieved using light in the near infrared (NIR) optical window. Optical absorption of intrinsic tissue chromophores enable rich anatomical contrast, while multispectral imaging permits the separation of distinct optical absorbers and promotes the applicability of MSOT for functional and molecular imaging. The utilized imaging setup consists of a tunable NIR laser (680-950nm) and a 64 element ultrasound transducer array covering 172° around the sample (center frequency 5Mhz) to achieve an in-plane resolution of ∼150µm; further detailed in A. Buehler et al, 2011, OpticsLetters. For the presented study 8-10 weeks old CD1 nude mice were stereotactically implanted with 105 U87MG cells stably expressing iRFP (Filonov, G.S. et al., NatBiotechnol, 2011) in depths of 1.5mm and 3.5mm. MSOT imaging was performed in vivo 12 and 25 days after implantation. Excellent accordance was observed between in vivo MSOT imaging and subsequent post-mortem epi-fluorescent cryoslicing, demonstrating the unique performance of optoacoustic imaging in the presented scenario. MSOT was able to discriminate the iRFP signal over strong background absorbers such as oxygenated and deoxygenated hemoglobin as early as 12 days post implantation of the tumor cells. MSOT offers considerable advantages over MRI and bioluminescent imaging, such as high spatial resolution, ease of use and cost-efficiency. The presented study illustrates the capabilities of this emerging imaging modality for the tracking of deep seated tumors with a multitude of settings and applications being feasible. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 2445. doi:1538-7445.AM2012-2445
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2012
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2014
    In:  Cancer Research Vol. 74, No. 19_Supplement ( 2014-10-01), p. 4310-4310
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 74, No. 19_Supplement ( 2014-10-01), p. 4310-4310
    Abstract: Pharmacokinetic imaging is a powerful platform for evaluating new candidate drugs and imaging agents, and multitude of applications have been demonstrated in DCE MRI. Interesting parameters such as Ktrans, half-life and Tmax can be retrieved for a tumor region after injection of a perfusion agent, allowing one to draw important conclusions on tumor growth, vascularization or therapy response. DCE MRI however is to a certain extent limited to magnetic agents and provides limited spatial and temporal resolution. Multispectral Optoacoustic Imaging (MSOT) is an emerging modality that combines ultrasound resolution of 150 µm and acquisition times of a few microseconds with optical contrast in the near infrared (NIR) spectral region. Multispectral imaging allows the localization of injected fluorophores without necessity of a baseline scan before injection, while a core imaging rate of 10 images/second allows the acquisition of a multispectral image within a second or even less. This enables fast image acquisition to support pharmacokinetic imaging, where the temporal profile of individual pixels is fit to a model equation and resulting parameters are plotted as parametric maps. Using targeted agents, binding specificity and its kinetics can be evaluated, while perfusion agents allow the assessment of perfusion and tissue uptake through Ktrans. One advantage in regards to DCE-MRI is the ability to extract the arterial input function from the data itself by monitoring a single cross-section with maximal temporal resolution. Another important feature is the use of intrinsic contrast that allows blood oxygenation quantification, enabling the co-registration of functional oxygenation measurements with DCE perfusion measurements. In particular, various algorithms can be applied in order to visualize blood oxygenation as a result from tissue intrinsic optoacoustic contrast without the injection of additional agents. These can be evaluated for pixel dependent temporal changes using the fast image acquisition techniques described above, which allows for tumor delineation and assessment of perfusion in a CO2 challenge experiment by visualizing the localized change in blood oxygenation. This can be cross-validated by the subsequent injection of a perfusion agent and evaluation of its transfer coefficient using DCE-MSOT techniques to paint a complete picture of the evaluated tumor microenvironment. The presented work uses the U87-MG glioblastoma and 4T1 tumors to illustrate the abilities of the technique in both subcutaneous and orthotopic settings. The extension of contrast-enhanced kinetic modeling to the optoacoustic imaging regime allows access to a library of optical probes that are otherwise unavailable to traditional DCE-MRI, while maintaining high spatial resolution and providing access to functional hemodynamic parameters. Citation Format: Stefan Morscher, Wouter HP Driessen, Neal C. Burton, Thomas Sardella, Daniel Razansky, Vasilis Ntziachristos. Assessing PK parameters using dynamic contrast enhanced multispectral optoacoustic tomography (DCE-MSOT). [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 4310. doi:10.1158/1538-7445.AM2014-4310
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2014
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2013
    In:  Cancer Research Vol. 73, No. 8_Supplement ( 2013-04-15), p. 737-737
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 73, No. 8_Supplement ( 2013-04-15), p. 737-737
    Abstract: Apoptosis is an important mechanism in cellular homeostasis and imbalances in the apoptotic process are associated with various disease states. An important example is the acquired ability of cancer cells to resist their own programmed cell death and therefore it is the aim of many tumor therapies to either reestablish pro-apoptotic signaling pathways or induce apoptosis through activation of existing mechanisms within the cell. Therefore, visualizing and quantifying the apoptotic process in vivo has great value in monitoring therapy response, diagnosis and staging disease. By being able to detect subtle changes in perfusion and tissue oxygenation, the small animal Multispectral Optoacoustic Tomography (MSOT) scanner offers unprecedented performance in cross-sectional imaging of tumor heterogeneity as well as a powerful capacity to simultaneously image molecular processes such as apoptosis by utilizing novel molecular probes. In this study, apoptotic regions within a mouse mammary tumor where visualized using a dye-conjugated caspase probe and compared to the hypoxia status of each tumor region. The temporal resolution of the MSOT small animal scanner (generation of multispectral cross-sectional data in less than 1 second) allows for the dynamic imaging of targeted and control probe simultaneously. To illustrate this point apoptosis probe was co-injected with a control dye with similar physical and chemical properties, but a different absorbance maximum after which the tumor region was imaged over 1 hour with multi-spectral image acquisition. Next, mice were imaged by MSOT immediately before and 24 hours post treatment with the chemotherapeutic Doxorubicin and the induction of apoptosis was visualized and quantified. Doxorubicin treatment led to a significant increase in signal resulting from the DyLight 747-conjugated apoptosis probe. In summary, MSOT can be used to determine the extent of apoptosis in tumors in vivo and thus has great value in monitoring therapy response, diagnosis and staging disease. Citation Format: Wouter H. Driessen, Neal C. Burton, Thomas Sardella, Stefan Morscher, Daniel Razansky, Vasilis Ntziachristos. Multispectral Optoacoustic Tomography (MSOT) imaging and quantification of apoptosis in vivo. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 737. doi:10.1158/1538-7445.AM2013-737
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2013
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2019
    In:  Cancer Research Vol. 79, No. 18 ( 2019-09-15), p. 4767-4775
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 79, No. 18 ( 2019-09-15), p. 4767-4775
    Abstract: Mapping tumor heterogeneity and hypoxia within a living intact organism is essential for understanding the processes involved in cancer progression and assessing long-term responses to therapies. Efficient investigations into tumor hypoxia mechanisms have been hindered by the lack of intravital imaging tools capable of multiparametric probing of entire solid tumors with high spatial and temporal resolution. Here, we exploit volumetric multispectral optoacoustic tomography (vMSOT) for accurate, label-free delineation of tumor heterogeneity and dynamic oxygenation behavior. Mice bearing orthotopic MDA-MB-231 breast cancer xenografts were imaged noninvasively during rest and oxygen stress challenge, attaining time-lapse three-dimensional oxygenation maps across entire tumors with 100 μm spatial resolution. Volumetric quantification of the hypoxic fraction rendered values of 3.9% to 21.2%, whereas the oxygen saturation (sO2) rate declined at 1.7% to 2.3% per mm in all tumors when approaching their core. Three distinct functional areas (the rim, hypoxic, and normoxic cores) were clearly discernible based on spatial sO2 profiles and responses to oxygen challenge. Notably, although sO2 readings were responsive to the challenge, deoxyhemoglobin (HbR) trends exhibited little to no variations in all mice. Dynamic analysis further revealed the presence of cyclic hypoxia patterns with a 21% average discrepancy between cyclic fractions assessed via sO2 (42.2% ± 17.3%) and HbR fluctuations (63% ± 14.1%) within the hypoxic core. These findings corroborate the strong potential of vMSOT for advancing preclinical imaging of cancer and informing clinical decisions on therapeutic interventions. Significance: vMSOT provides quantitative measures of volumetric hypoxic fraction and cyclic hypoxia in a label-free and noninvasive manner, providing new readouts to aid tumor staging and treatment decision making.
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2019
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 6
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2014
    In:  Cancer Research Vol. 74, No. 19_Supplement ( 2014-10-01), p. 2050-2050
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 74, No. 19_Supplement ( 2014-10-01), p. 2050-2050
    Abstract: In designing new biomarker imaging approaches for cancer research, the heterogeneity and dynamics of the tumor microenvironment cannot be disregarded. The interplay between the different components of the tumor stroma and parenchyma play a significant role in tumor progression, invasion and treatment response. In order to study such dynamic processes by (molecular) imaging, volumetric imaging modalities with a high temporal and spatial resolution need to be combined with contrast agents that possess appropriate pharmacokinetic parameters. In this work, we assessed tumor heterogeneity and specific cell-populations within the tumor microenvironment by combining Multispectral Optoacoustic Tomography (MSOT) with three different fast-clearing contrast agents. MSOT is a biomedical imaging modality based on the photoacoustic effect. In the used setup, mice are illuminated at multiple wavelengths in the NIR range (680 - 980nm) and by detecting the acoustic waves with a 5MHz tomographic ultrasound array, cross-sectional images can be obtained at a resolution of 150µm in less than a second. Imaging multiple cross-sections allows for volumetric reconstruction of the data and multispectral data analysis enables the specific identification of endogenous absorbers (hemoglobin and melanin) and/or multiple injected contrast agents. The pharmacokinetic parameters of the imaging agents were optimized to allow for relatively fast imaging regimens ( & lt;1 hour) that can be employed daily. Firstly, we assessed inter- and intra-tumoral heterogeneity in tumor perfusion and vascular permeability by systemically administering novel formulations of Indocyanine Green (ICG). Pixel-by-pixel analysis was then performed to create parametric maps, thereby revealing a high degree of heterogeneity in dynamic contrast enhancement between and within tumors. Secondly, apoptotic regions within orthotopic tumors were visualized using a caspase-targeted probe and compared to the hypoxia status of each tumor region, before and after treatment. Before treatment, maximal apoptosis-signal was co-localized with more hypoxic regions in the tumor. However, overall signal intensity was significantly increased after systemic treatment with doxorubicin. Lastly, the tumor associated macrophage (TAM) cell population within the tumor stroma was visualized by a novel NIR marker specific for macrophage. Again, intra-tumoral distribution of TAM-specific signal was compared to images of Hb and HbO2, revealing higher TAM densities in areas of relative hypoxia. In summary, MSOT offers an imaging modality that can provide anatomical, functional, molecular and kinetic information at high temporal and spatial resolution. When combined with (molecular) imaging agents that possess appropriate pharmacokinetic properties, this modality can be leveraged for new biomarker imaging approaches in cancer research. Citation Format: Stefan Morscher, Neal C. Burton, Thomas Sardella, Daniel Razansky, Vasilis Ntziachristos, Wouter H. P. Driessen. Novel approaches for dynamic tumor microenvironment imaging by Multispectral Optoacoustic Tomography (MSOT). [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 2050. doi:10.1158/1538-7445.AM2014-2050
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2014
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 7
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 72, No. 8_Supplement ( 2012-04-15), p. 2440-2440
    Abstract: Brain research has been revolutionized by imaging technologies. X-ray CT and MRI provide high spatial resolution, revealing anatomical anomalies indicative of disease. PET and optical imaging have target specificity, allowing the visualization of molecular events. Intravital microscopy has specificity and resolution, providing key information on pathological micro-events, but lacks penetration depth. Multi-spectral optoacoustic tomography (MSOT) combines high resolution, molecular specificity and depth to achieve non-invasive in vivo anatomical, functional and molecular imaging in deep tissue. MSOT illuminates tissue with light pulses at multiple wavelengths and detects the acoustic waves generated by the thermoelastic expansion following light absorption. Using spectral analysis of the data collected, MSOT can then differentiate the spectral signatures of endogenous biomarkers such as oxy-/deoxy-hemoglobin and of photo-absorbing agents and quantify their concentration. In this work we explore the potential of MSOT in cross-sectional imaging of the mouse brain and contrast these results with MRI and ex vivo brain imaging to validate the MSOT in vivo findings. 8 week old nude CD-1 mice were used for stereotactic implantation of U87 glioblastoma cells and for imaging of hemoglobin contrast and ICG biodistribution. In vivo MSOT of the intact mouse head yielded unprecedented performance in cross-sectional imaging of the mouse brain by visualizing the overall brain outline and anatomy, and imaging temporal arteries and blood vessels beneath the skull. Additionally, NIR probes were injected into the 3rd ventricle, with an excellent correlation between MSOT and fluorescence imaging of cryoslices, demonstrating the capacity of MSOT to localize NIR probes in the brain through intact skin and skull with high accuracy. In addition, spectral decomposition of hemoglobin confirmed the MSOT ability to visualize well perfused and ischemic brain conditions following a CO2 challenge. Additionally, MSOT accurately visualized ICG bio-distribution injected into the tail vein, and followed in real time the ICG kinetics and clearance. Finally, spectral decomposition of deoxygenated hemoglobin allowed the observation of hypoxia related to the growth of U87 tumor cells injected into the striatum. Multispectral processing allowed the visualization of the true organ distribution of IntegriSense and AngioSense in the brain, with planar fluorescence imaging used for a reference comparison. The application of MSOT in in vivo brain imaging is demonstrated. MSOT can be used to follow changes in blood oxygenation, as well as the distribution of near-infrared probes. With the advent of new molecular probes, MSOT could also track molecular features of neurological disease and cancer in mouse models. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 2440. doi:1538-7445.AM2012-2440
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2012
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...